ResMed Inc.
RMD · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5,146,327 | $4,685,297 | $4,222,993 | $3,578,127 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Cost of Goods Sold | $2,091,357 | $2,029,994 | $1,867,331 | $1,553,816 |
| Gross Profit | $3,054,970 | $2,655,303 | $2,355,662 | $2,024,311 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| R&D Expenses | $331,284 | $307,525 | $287,642 | $253,575 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $991,019 | $917,136 | $874,003 | $739,372 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $47,304 | $110,749 | $62,146 | $31,078 |
| Operating Expenses | $1,369,607 | $1,335,410 | $1,223,791 | $1,024,025 |
| Operating Income | $1,685,363 | $1,319,893 | $1,131,871 | $1,000,286 |
| % Margin | 32.7% | 28.2% | 26.8% | 28% |
| Other Income/Exp. Net | -$7,797 | -$55,095 | -$30,207 | -$39,803 |
| Pre-Tax Income | $1,677,566 | $1,264,798 | $1,101,664 | $960,483 |
| Tax Expense | $276,843 | $243,847 | $204,108 | $181,046 |
| Net Income | $1,400,723 | $1,020,951 | $897,556 | $779,437 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS | 9.55 | 6.94 | 6.12 | 5.34 |
| % Growth | 37.6% | 13.4% | 14.6% | – |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| Weighted Avg Shares Out | 146,716 | 147,021 | 146,765 | 146,066 |
| Weighted Avg Shares Out Dil | 147,340 | 147,550 | 147,455 | 147,043 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $12,609 | $45,708 | $47,379 | $22,312 |
| Depreciation & Amortization | $235,811 | $216,209 | $196,522 | $193,841 |
| EBITDA | $1,913,377 | $1,533,543 | $1,358,801 | $1,176,636 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |